Determinants of Hospital Length of Stay Among Pulmonary Tuberculosis Inpatients at A Secondary General Hospital in Indonesia: A Comparative Analysis
DOI:
https://doi.org/10.37034/medinftech.v4i2.150Keywords:
Comorbidity, Length of Stay, INA-CBGs, , Hospitalization, Pulmonary TuberculosisAbstract
Tuberculosis (TB) remains a major public health challenge in Indonesia, which has the second-highest TB burden globally. Hospital length of stay (LOS) is an important indicator of inpatient care efficiency and influences reimbursement under the Indonesia Case-Based Groups (INA-CBGs) payment system. However, evidence regarding determinants of LOS in Indonesian secondary hospitals is still limited. This retrospective comparative study analyzed secondary medical-record data from a secondary general hospital in Medan, North Sumatra, collected between January and August 2025. Among 238 identified records, 215 patients with a primary diagnosis of pulmonary TB (ICD-10: A15.0–A16.9) met the inclusion criteria. LOS was calculated from admission and discharge dates. As LOS was not normally distributed (Shapiro–Wilk, p < 0.001), the Kruskal–Wallis and Mann–Whitney U tests with Dunn post-hoc correction were applied (α = 0.05). The median LOS was 3 days (IQR 2–4; range 0–13). Most patients were younger than 65 years (75.3%), while 51.2% had no documented comorbidity. Comorbidity burden was the only factor significantly associated with LOS (H = 18.74, p < 0.001; η² = 0.082). Patients with two or more comorbidities had significantly longer hospitalization than those without comorbidities (mean 4.18 vs. 2.82 days; p < 0.001) and those with one comorbidity (p = 0.013). No significant differences were found according to age group or insurance status. These findings indicate that comorbidity burden contributes to prolonged hospitalization among pulmonary TB inpatients and support integrating multimorbidity management into TB care. Larger multicenter prospective studies are needed to validate these findings.
Downloads
References
World Health Organization, “Global Tuberculosis Report 2024,” Geneva: World Health Organization. [Online]. Available: https://www.who.int/publications/i/item/9789240101531
Ministry of Health of the Republic of Indonesia, Profil Kesehatan Indonesia 2022. Jakarta: Kementerian Kesehatan RI, 2023.
Y. Zhang et al., “Length of hospital stay among pulmonary tuberculosis patients: A systematic review and meta-analysis,” Int. J. Infect. Dis., vol. 116, pp. 245–254, 2022, doi: 10.1016/j.ijid.2022.01.023.
B. Aji, S. Mohammed, P. Haryanto, M. Yamin, and M. D. Allegri, “The dynamics of catastrophic and impoverishing health spending in Indonesia: How well does the Indonesian National Health Insurance protect against financial risk?,” PLoS One, vol. 17, no. 2, 2022, doi: 10.1371/journal.pone.0263710.
R. Thabrany, D. Setiawan, A. Kusuma, and W. Rukmini, “Hospital efficiency and INA-CBGs reimbursement: A cross-sectional study of inpatient length of stay in Indonesian national referral hospitals,” BMC Health Serv. Res., vol. 22, no. 1, p. 1184, 2022, doi: 10.1186/s12913-022-08558-8.
F. A. Putri and A. Suryadi, “Faktor-faktor yang mempengaruhi lama rawat inap pasien tuberkulosis paru di Rumah Sakit Umum Daerah,” J. Kesehat. Masy., vol. 9, no. 2, pp. 145–153, 2021.
N. Arifin, R. Hariyanto, and M. Husni, “Determinants of length of hospital stay among pulmonary tuberculosis patients in Indonesian district hospitals: A multicenter retrospective cohort study,” Int. J. Environ. Res. Public Health, vol. 19, no. 14, p. 8412, 2022, doi: 10.3390/ijerph19148412.
R. D. Handayani, D. Setiawan, and A. Kusuma, “Analysis of length of stay and treatment cost of tuberculosis inpatients in Indonesian hospitals under the National Health Insurance program,” J. Public health Res., vol. 11, no. 3, 2022, doi: 10.4081/jphr.2022.2263.
M. Nkosi, N. Sewram, and T. Motsepe, “Predictors of prolonged hospitalization among pulmonary tuberculosis inpatients in South Africa: A retrospective registry-based analysis,” PLoS One, vol. 17, no. 6, 2022, doi: 10.1371/journal.pone.0268951.
H. Tomczak and T. Tomczak, “The need to report effect size estimates revisited: An overview of some recommended measures of practical significance,” Trends Sport Sci., vol. 1, no. 21, pp. 19–25, 2014.
Q. Liu et al., “Factors affecting time to sputum culture conversion and length of hospital stay in patients with multidrug-resistant tuberculosis in eastern China,” BMC Infect. Dis., vol. 23, no. 1, p. 78, 2023, doi: 10.1186/s12879-023-08051-z.
A. Kumar, R. Gupta, P. Singh, and S. K. Sharma, “Impact of HIV co-infection and nutritional status on length of hospital stay among pulmonary tuberculosis patients in high-burden settings: A multicenter cohort study,” Int. J. Infect. Dis., vol. 121, pp. 112–120, 2022, doi: 10.1016/j.ijid.2022.05.014.
Ministry of Health of the Republic of Indonesia, Petunjuk Teknis Tata Laksana Tuberkulosis. Jakarta: Direktorat Jenderal Pencegahan dan Pengendalian Penyakit, 2024.
B. Alisjahbana et al., “The effect of type 2 diabetes mellitus on the presentation and treatment response of pulmonary tuberculosis,” Clin. Infect. Dis., vol. 45, no. 4, pp. 428–435, 2007, doi: 10.1086/519841.
W. Yuniar, T. A. Murni, and R. Sartika, “Tuberculosis-diabetes mellitus comorbidity and its effect on sputum conversion and length of hospital stay: A systematic review and meta-analysis of studies in Asia,” BMC Infect. Dis., vol. 23, no. 1, p. 315, 2023, doi: 10.1186/s12879-023-08234-8.
V. Chidambaram et al., “Factors associated with disease severity and mortality among patients with pulmonary tuberculosis: A systematic review and meta-analysis,” PLoS One, vol. 16, no. 8, 2021, doi: 10.1371/journal.pone.0256744.
R. D. Handayani, B. Setiawan, and A. Prasetyowati, “Disease severity and clinical predictors of prolonged length of stay in pulmonary tuberculosis inpatients at secondary hospitals in Indonesia,” Kesmas Natl. Public Heal. Journal, vol. 17, no. 2, pp. 89–96, 2022, doi: 10.21109/kesmas.v17i2.5682.
M. A. Hossain, F. Nahar, S. Ahmed, and M. Islam, “Age, comorbidity, and clinical pathway standardization as predictors of tuberculosis hospitalization duration in low- and middle-income countries: A systematic review,” Trop. Med. Int. Heal., vol. 28, no. 4, pp. 287–298, 2023, doi: 10.1111/tmi.13857.







